Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.80B | $169.75 | $177.50 | 4.57% | Strong Buy | 4 | 103.50% | 52.91% | N/A | N/A | ||||
| GMAB | GENMAB A | $19.50B | $29.51 | $45.00 | 52.49% | Buy | 4 | 21.82% | 48.09% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.17B | $14.07 | $27.50 | 95.45% | Strong Buy | 4 | 38.43% | 139.09% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $4.91B | $38.72 | $54.17 | 39.89% | Buy | 6 | 15.99% | 48.53% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.68B | $29.52 | $38.00 | 28.73% | Buy | 7 | 17.13% | 42.05% | N/A | N/A | ||||
| INCY | INCYTE CORP | $12.00B | $53.43 | $73.92 | 38.34% | Buy | 12 | 11.49% | 52.77% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $933.19M | $6.35 | $12.67 | 99.48% | Strong Buy | 3 | 11.82% | 25.46% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $17.27B | $91.51 | $101.30 | 10.70% | Buy | 10 | 12.20% | 94.71% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.40B | $23.15 | $36.00 | 55.51% | Strong Buy | 3 | 16.84% | 29.98% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.88B | $28.25 | $46.75 | 65.49% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $233.60M | $4.06 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $10.30B | $65.52 | $77.83 | 18.79% | Strong Buy | 6 | 6.84% | 29.33% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.88B | $22.70 | $27.17 | 19.68% | Buy | 6 | 8.37% | 55.63% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.91B | $110.91 | $193.09 | 74.10% | Strong Buy | 11 | 6.52% | 64.32% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $257.91M | $5.35 | $7.00 | 30.84% | Buy | 1 | 0.26% | 31.88% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $20.89B | $87.89 | $114.25 | 29.99% | Hold | 8 | -10.66% | 36.84% | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $140.31M | $2.07 | $11.00 | 431.40% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.81B | $15.39 | $27.40 | 78.04% | Strong Buy | 5 | 16.34% | 16.52% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $558.79B | $123.90 | $133.00 | 7.34% | Strong Buy | 6 | 21.03% | 4.76% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.06B | $235.08 | $298.00 | 26.77% | Strong Buy | 7 | 9.50% | 8.78% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $98.63B | $898.56 | $987.06 | 9.85% | Buy | 16 | 7.46% | 4.84% | N/A | N/A | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $102.64B | $397.36 | $445.47 | 12.11% | Buy | 15 | 9.00% | 2.45% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.